Biotechnology Equipment Global Market Report 2025

The biotechnology equipment market size has grown rapidly in recent years. It will grow from $64.3 billion in 2024 to $74.83 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth during the historic period can be credited to the expansion of biopharmaceutical manufacturing, the rise in cell and gene therapies, the increasing use of automated laboratory systems, the growing demand for point-of-care diagnostics, and the integration of AI into biotechnology research.

The biotechnology equipment market size is expected to see rapid growth in the next few years. It will grow to $135.91 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The anticipated growth in the forecast period can be attributed to increased government funding in life sciences, a rise in pharmaceutical R&D activities, expansion of academic research institutions, growing demand for personalized medicine, and the increasing need for high-throughput screening. Key trends expected during this period include the miniaturization of biotechnology equipment, a shift towards single-use technologies, the adoption of lab-on-a-chip systems, the use of 3D printing in laboratory equipment, and the expansion of cloud-based laboratory data management systems.

The rising demand for personalized medicine is projected to drive the growth of the biotechnology equipment market in the coming years. Personalized medicine refers to customizing medical treatment based on individual characteristics such as genetic profile, lifestyle, and environmental factors to improve treatment effectiveness and minimize adverse effects. This growing demand is largely fueled by advancements in genetic and molecular profiling technologies, which allow for more precise and individualized therapies. Biotechnology equipment plays a crucial role in supporting personalized medicine by offering accurate tools to analyze genetic and molecular data, thereby facilitating tailored treatments that enhance patient outcomes and reduce side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023 - a notable rise from six approvals in 2022. Among these, seven were cancer treatments, while three targeted other diseases and conditions. Hence, the growing demand for personalized medicine is contributing significantly to the expansion of the biotechnology equipment market.

Leading companies in the biotechnology equipment market are concentrating on developing innovative technologies such as qPCR systems to improve the accuracy, speed, and efficiency of genetic analysis. qPCR (quantitative polymerase chain reaction) systems are specialized laboratory instruments that amplify and simultaneously quantify specific DNA or RNA sequences in real time. These systems support biotechnology applications by enabling accurate gene expression analysis, mutation detection, and disease diagnostics, thereby advancing research, clinical testing, and targeted therapy development. For example, in September 2024, Takara Bio USA, Inc., a U.S.-based manufacturing firm, introduced the SmartChip ND Real-Time PCR System - a high-throughput, automated qPCR platform designed to enhance antimicrobial resistance surveillance through flexible, nanoliter-scale reactions and minimal hands-on time. This next-generation system supports up to 5,184 nanoliter-scale reactions per chip and requires less than 30 minutes of manual setup. It eliminates the need for preamplification, which reduces reagent costs and experimental variability. With its compact build and adaptable configuration, the SmartChip ND system is ideal for environmental surveillance labs seeking cost-effective monitoring of large panels of AMR-related genes.

In January 2024, Calibre Scientific, a U.S.-based company known for producing and supplying high-quality laboratory instruments, acquired Lab Tech S.r.l for an undisclosed sum. This acquisition is intended to enhance Calibre Scientific’s presence in the life sciences industry by broadening its range of laboratory instruments and consumables. Lab Tech S.r.l, a UK-based manufacturer, specializes in biotechnology equipment, including centrifuges, shakers, incubators, and pipetting systems.

Major players in the biotechnology equipment market are Hoffmann-La Roche Aktiengesellschaft, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Carl Zeiss AG, Alcon Inc., Avantor Inc., Agilent Technologies Inc., Illumina Inc., Sartorius Aktiengesellschaft, PerkinElmer Inc., Mettler-Toledo International Inc., Shimadzu Corporation, Candela Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Büchi Labortechnik AG, Eppendorf SE, BioTek Instruments Inc., bioMérieux S.A., Cynosure LLC, AngioDynamics Inc.

North America was the largest region in the biotechnology equipment market in 2024. The regions covered in biotechnology equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biotechnology equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biotechnology equipment comprises specialized tools, instruments, and devices designed to support and execute a range of biological and biochemical processes involved in research, development, and production within the biotechnology sector. This equipment plays a crucial role in activities like genetic engineering, cell culture, molecular analysis, fermentation, and drug development.

The primary categories of biotechnology equipment include lab automation instruments, life science consumables, in vitro diagnostics (IVD) instruments, medical lasers, and other related products. Lab automation instruments are designed to simplify repetitive laboratory tasks, improving efficiency, precision, and enabling high-throughput operations. These tools are employed in various fields such as life sciences, clinical diagnostics, quality control, and food and beverage analysis. A broad spectrum of end-users, including pharmaceutical companies, academic and government research institutions, hospitals, and healthcare facilities, as well as other industries, utilize these instruments.

The biotechnology equipment market research report is one of a series of new reports that provides biotechnology equipment market statistics, including biotechnology equipment industry global market size, regional shares, competitors with the biotechnology equipment market share, detailed biotechnology equipment market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology equipment industry. This biotechnology equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biotechnology equipment market includes sales of centrifuges, bioreactors, PCR machines, spectrophotometers, microscopes, chromatography systems, electrophoresis equipment, automated liquid handling systems, incubators, shakers, freeze dryers, microarray systems, and flow cytometers.Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.